Open Accessibility Menu

Clinical Trial Information

Efficacy of Hookworm Vaccine Assessed by Controlled Challenge Infection

Study Details

This is a 14-month, randomized, Phase 2 clinical study comparing the impact of Na-GST-1 vaccination on controlled human hookworm infection in healthy volunteers. Participants will receive 3 injections of the investigational hookworm vaccine (or placebo), followed by infection with 50 human hookworm larvae.

Primary Sponsor:

NIH

Prinicipal Investigator:

David Diemert, MD/Medicine

Contact Phone:

(202) 994-8976
Efficacy of Hookworm Vaccine Assessed by Controlled Challenge Infection dbcampbell@email.gwu.edu

Interested in More Information

  • Please enter your first name.
  • Please enter your last name.
  • This isn't a valid email address.
    Please enter your email address.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • Please enter your address.
  • Please enter your city.
  • Please enter your state.
  • Please enter your zip code.
  • (All Uppercase. No Spaces)